| Net Cash Provided by (Used in) Operating Activities |
$2,200,000,000 |
USD |
-2.1% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$2,119,000,000 |
USD |
-19% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$3,603,000,000 |
USD |
352% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
4,000,000,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
833,984,684 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$16,287,000,000 |
USD |
-9.4% |
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Valuation Allowance |
$20,000,000 |
USD |
11% |
Q4 2024 |
FY 2024 |
| Deferred Tax Assets, Gross |
$3,067,000,000 |
USD |
4.3% |
Q4 2024 |
FY 2024 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$3,579,000,000 |
USD |
11% |
Q3 2025 |
Q3 2025 |
| Deferred Income Tax Expense (Benefit) |
$54,000,000 |
USD |
100% |
Q1 2025 |
Q1 2025 |
| Preferred Stock, Shares Issued |
1,250,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
1,250,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Unrecognized Tax Benefits |
$236,000,000 |
USD |
1.7% |
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
$9,866,000,000 |
USD |
0.45% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
1,250,000 |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Depreciation, Depletion and Amortization |
$125,000,000 |
USD |
5% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$3,047,000,000 |
USD |
4.2% |
Q4 2024 |
FY 2024 |
| Interest Expense |
$4,139,000,000 |
USD |
105% |
Q1 2024 |
Q1 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |